NICE is recommending BOTOX® (botulinum toxin type A) for the prophylaxis (prevention) of headache in adults with chronic migraine*, specifically in patients who have not responded to at least three prior preventative treatments and whose condition is appropriately managed for medication overuse.

• BOTOX® treatment can provide significant benefit to patients with chronic migraine, helping to reduce the number of days disrupted by migraine or headache and improving their quality of life.  Patients who respond to BOTOX® describe the treatment as life changing and for refractory patients who have exhausted other options, a reduction in the number of headache days can have a very significant impact on everyday life, like being able to do the school run, attend a meeting or visit relatives.
• Allergan’s BOTOX® is the only botulinum toxin type A to have received authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) for the prevention of headache in chronic migraine*. Treatment (155-195 Units) consists of 31-39 injections into specific sites across the forehead, side of the head and neck and is administered about every 3 months.

• Currently, chronic migraine is under-diagnosed and under treated, and has a significant clinical, social and economic burden. Existing treatments provide little relief when used by patients with chronic migraine and are associated with contraindications and poor tolerability.
• People who think they may suffer from chronic migraine should seek a consultation with a headache or migraine specialist or a neurologist.

* Chronic migraine is defined as headaches on at least 15 days per month of which at least 8 days are with migraine

For further information about the benefits of BOTOX treatments contact our Nottingham or London clinic by calling 0115 9596 999 or complete our online enquiry form and we will contact you